Gut microbiome plays a vital role in post-stroke injury repair by mediating neuroinflammation

Int Immunopharmacol. 2023 May:118:110126. doi: 10.1016/j.intimp.2023.110126. Epub 2023 Apr 7.

Abstract

Cerebral stroke is a common neurological disease and often causes severe neurological deficits. With high morbidity, mortality, and disability rates, stroke threatens patients' life quality and brings a heavy economic burden on society. Ischemic cerebral lesions incur pathological changes as well as spontaneous nerve repair following stroke. Strategies such as drug therapy, physical therapy, and surgical treatment, can ameliorate blood and oxygen supply in the brain, hamper the inflammatory responses and maintain the structural and functional integrity of the brain. The gut microbiome, referred to as the "second genome" of the human body, participates in the regulation of multiple physiological functions including metabolism, digestion, inflammation, and immunity. The gut microbiome is not only inextricably associated with dangerous factors pertaining to stroke, including high blood pressure, diabetes, obesity, and atherosclerosis, but also influences stroke occurrence and prognosis. AMPK functions as a hub of metabolic control and is responsible for the regulation of metabolic events under physiological and pathological conditions. The AMPK mediators have been found to exert dual roles in regulating gut microbiota and neuroinflammation/neuronal apoptosis in stroke. In this study, we reviewed the role of the gut microbiome in cerebral stroke and the underlying mechanism of the AMPK signaling pathway in stroke. AMPK mediators in nerve repair and the regulation of intestinal microbial balance were also summarized.

Keywords: Gut microbiome; Neurological functions; Recovery; Signaling pathway; Stroke.

Publication types

  • Review

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Brain / metabolism
  • Gastrointestinal Microbiome* / physiology
  • Humans
  • Nervous System Diseases* / metabolism
  • Neuroinflammatory Diseases
  • Stroke* / drug therapy

Substances

  • AMP-Activated Protein Kinases